AI Science Tracker
EN

Prediction of high-flow nasal cannula failure in COVID-19 acute hypoxemic respiratory failure using combined clinical and metabolomic data: a machine learning study.

Hospital del Mar; Hospital del Mar Research Institute; Universitat Pompeu Fabra · 30 Oct 2026 · medicine

Discovery

Prediction of high-flow nasal cannula failure in COVID-19 acute hypoxemic respiratory failure using combined clinical and metabolomic data: a machine learning study.

Source check: Source checked. Not independent scientific confirmation.

Finding: A random-forest model combined clinical and metabolomic data to predict high-flow nasal cannula failure in a prospective COVID-19 cohort. A temporally independent cohort was also examined, but it included only 22 patients; this does not establish clinical utility.

Technology: Random-forest prediction using clinical and metabolomic features

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Random-forest prediction using clinical and metabolomic features
Test and result
Prospective cohort evaluation and temporal validation were reported; the temporal cohort contained 22 patients.
Limitation / still unknown
The temporal sample is small, and prediction performance does not establish improved treatment decisions or patient outcomes.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13759415/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.